Cost-effectiveness analysis of exenatide twice daily (BID)...

  • Main
  • 2015 / 07
  • Cost-effectiveness analysis of exenatide twice daily (BID)...

Cost-effectiveness analysis of exenatide twice daily (BID) versus insulin glargine once daily (QD) as add-on therapy in Chinese patients with Type 2 diabetes mellitus inadequately controlled by oral therapies

Deng, Jing, Gu, Shuyan, Shao, Hui, Dong, Hengjin, Zou, Dajin, Shi, Lizheng
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.3111/13696998.2015.1067622
Date:
July, 2015
File:
PDF, 1.22 MB
english, 2015
Conversion to is in progress
Conversion to is failed